Live · 22 Oct 2026 SPX 7,640.20 -1.51% NDX 28,889.97 -3.13% VIX 19.94 +19.54% GOLD 4,048.10 -2.46% CL 99.48 -2.27% BTC 81,293.02 -3.24%
NAS100 28,890 −3.13% S&P 7,640 −1.51% GOLD $4,048 −2.46% BTC $81,293 −3.24% VIX 19.94 +19.54% live tape · as of 19:01 UTC
Vol. II · No. 295Thursday, 22 October 2026
TTitan Protect
Case Studies · Earnings Echo

Thermo Fisher Scientific Is Priced for a Flawless Print, at 37x

Filed Wednesday 21 October 2026 · 12:53 UTC · Entry no. 131139 · scored against the close · never edited

Thermo Fisher Scientific Is Priced for a Flawless Print, at 37x
Earnings Preview · 21 October 2026
Where our screen stands going in
The two standards split: it clears the faith-based (AAOIFI) screen but not our broader anchor screen. We default to protection and do not call it compliant on a divergence.
What the Street expects
Consensus looks for earnings of about $6.40 a share on revenue near $12.0B. Over the next twelve months analysts pencil in $27.58 of earnings per share against $18.86 over the last twelve, growth of about 46%. The median analyst target is $705 (range $560 to $800), 6% above the $667.59 share price, across 26 analysts.
How it has traded on past prints
Across the last 25 reports, the shares moved an average of -1.0% in the five sessions after the print and -2.7% over twenty. There is no reliable drift pattern: the first move has often faded, so chasing the gap has not paid.
What options are pricing
Implied volatility near 72% prices a one-week move of roughly ±9.9% (about $601.49 to $733.69). Positioning: the heaviest put open interest sits at $670 and the heaviest call open interest at $740; those strikes tend to act as magnets or walls in the days after.
Levels that matter
At $667.59 the shares sit 5% below the 52-week high of $701.64 and 53% above the low of $435.27 (87% of the way up the range). The 50-day average is $632.11, below the price. The 200-day average is $559.79, below the price.
Valuation going in
The shares trade close to our fair-value estimate (-2% margin of safety): fairly priced, little cushion for a miss. Our fair-value estimate is $655.86 against the current share price of $667.59. The shares trade at 36.9 times trailing earnings and 25.3 times forward earnings. Revenue is growing about 10% with net margins near 15%.
Our stance
We are not participants, the name fails our principled screen, so we watch it as a sentiment gauge, not a holding.
What the flow says going in
Price has run up but the money has been quietly leaving: distribution into strength. For a holder that is a trim-or-take-profit signal, not an add; the crowd sees the strength, the flow sees the exit. (21-day Chaikin Money Flow +0.18, five-day price change +3.7%, as of 2026-10-20, desk flow model).

This is analysis, not financial advice. Always manage your risk.

How This Entry Scores

Every level named in a session brief is scored against the next scheduled close. Nothing is edited after filing: if a level breaks, the record shows it as filed, not as corrected. The desk's full scored history sits on the track record page.

Continue Reading View all Case Studies →
Membership

The ledger is public. The desk behind it is not.

Membership opens every room and every entry the day it is filed, with the same dated honesty the record is built on.

Join the desk

This is analysis, not financial advice. Always manage your risk.

Get our weekly market brief free.